Temat: "Immunoglobulin G" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022.
Autorzy :: Atyeo C; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.; Program in Virology, Division of Medical Sciences, Harvard University, Boston, Massachusetts, USA.
Slein MD; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
Fischinger S; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.; Program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany.
Burke J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
Schäfer A; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Leist SR; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Kuzmina NA; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Galveston National Laboratory, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA.
Mire C; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Galveston National Laboratory, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA.
Honko A; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA.
Johnson R; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA.
Storm N; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA.
Bernett M; Xencor, Monrovia, California, USA.
Tong P; Department of Medicine, Brigham and Women's Hospital; Division of Allergy and Clinical Immunology; and Division of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
Zuo T; Department of Medicine, Brigham and Women's Hospital; Division of Allergy and Clinical Immunology; and Division of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
Lin J; Department of Medicine, Brigham and Women's Hospital; Division of Allergy and Clinical Immunology; and Division of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
Zuiani A; Department of Medicine, Brigham and Women's Hospital; Division of Allergy and Clinical Immunology; and Division of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
Linde C; SeromYx Systems, Cambridge, Massachusetts, USA.
Suscovich T; SeromYx Systems, Cambridge, Massachusetts, USA.
Wesemann DR; Department of Medicine, Brigham and Women's Hospital; Division of Allergy and Clinical Immunology; and Division of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
Griffiths A; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA.
Desjarlais JR; Xencor, Monrovia, California, USA.
Juelg BD; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
Goudsmit J; Departments of Epidemiology and Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Bukreyev A; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Galveston National Laboratory, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA.; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Baric R; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Departments of Microbiology and Immunology and Genetics, School of Medicine, and.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.; Pokaż więcej
Źródło :: JCI insight [JCI Insight] 2021 Jan 11; Vol. 6 (1). Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Antibodies, Neutralizing/*pharmacology
COVID-19/*immunology
Immunity, Innate/*drug effects
Immunoglobulin Fc Fragments/*genetics
Immunoglobulin G/*pharmacology
SARS-CoV-2/*drug effects
Virus Replication/*drug effects
Animals ; Antibodies, Monoclonal ; Antibodies, Neutralizing/genetics ; Antibodies, Neutralizing/therapeutic use ; COVID-19/drug therapy ; COVID-19/physiopathology ; Cricetinae ; Cross Reactions ; Epitopes ; Humans ; Immunity, Innate/immunology ; Immunoglobulin G/genetics ; Immunoglobulin G/therapeutic use ; Mesocricetus ; Mice ; Middle East Respiratory Syndrome Coronavirus/drug effects ; Middle East Respiratory Syndrome Coronavirus/immunology ; Protein Engineering ; Receptors, Fc/immunology ; SARS Virus/drug effects ; SARS Virus/immunology ; SARS-CoV-2/immunology ; Severity of Illness Index ; Spike Glycoprotein, Coronavirus/immunology ; THP-1 Cells ; Viral Load/drug effects ; Weight Loss/drug effects
SCR Protocol :: COVID-19 drug treatment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters.
Autorzy :: Fagre AC; Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Manhard J; AvantGen, Inc. San Diego, CA, United States.
Adams R; AvantGen, Inc. San Diego, CA, United States.
Eckley M; Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Zhan S; Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Lewis J; Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Rocha SM; Department of Environmental and Radiological Health Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Woods C; AvantGen, Inc. San Diego, CA, United States.
Kuo K; AvantGen, Inc. San Diego, CA, United States.
Liao W; AvantGen, Inc. San Diego, CA, United States.
Li L; AvantGen, Inc. San Diego, CA, United States.
Corper A; AvantGen, Inc. San Diego, CA, United States.
Challa D; AvantGen, Inc. San Diego, CA, United States.
Mount E; AvantGen, Inc. San Diego, CA, United States.
Tumanut C; AvantGen, Inc. San Diego, CA, United States.
Tjalkens RB; Department of Environmental and Radiological Health Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Aboellail T; Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Fan X; AvantGen, Inc. San Diego, CA, United States.
Schountz T; Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.; Pokaż więcej
Źródło :: Frontiers in immunology [Front Immunol] 2020 Dec 18; Vol. 11, pp. 614256. Date of Electronic Publication: 2020 Dec 18 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Antibodies, Monoclonal*/immunology
Antibodies, Monoclonal*/pharmacology
Antibodies, Neutralizing*/immunology
Antibodies, Neutralizing*/pharmacology
Antibodies, Viral*/immunology
Antibodies, Viral*/pharmacology
COVID-19*/blood
COVID-19*/drug therapy
COVID-19*/immunology
Immunoglobulin G*/immunology
Immunoglobulin G*/pharmacology
SARS-CoV-2/*immunology
Animals ; Chlorocebus aethiops ; Humans ; Male ; Mesocricetus ; Severity of Illness Index ; Vero Cells ; Viral Load/drug effects ; Viral Load/immunology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization.
Autorzy :: Salazar E; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.
Kuchipudi SV; Penn State Animal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, and.; Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, Pennsylvania, USA.
Christensen PA; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.
Eagar T; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.
Yi X; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.
Zhao P; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.
Jin Z; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.
Long SW; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.; Center for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.
Olsen RJ; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.; Center for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.
Chen J; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.
Castillo B; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.
Leveque C; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.
Towers D; Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
Lavinder J; Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
Gollihar J; Combat Capabilities Development Command Army Research Laboratory - South, University of Texas, Austin, Texas, USA.
Cardona J; Combat Capabilities Development Command Army Research Laboratory - South, University of Texas, Austin, Texas, USA.
Ippolito G; Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.; Department of Oncology, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.
Nissly R; Penn State Animal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, and.
Bird I; Penn State Animal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, and.
Greenawalt D; Penn State Animal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, and.
Rossi RM; Huck Institutes of the Life Sciences and.
Gontu A; Penn State Animal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, and.
Srinivasan S; Huck Institutes of the Life Sciences and.
Poojary I; Huck Institutes of the Life Sciences and.
Cattadori IM; Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, Pennsylvania, USA.; Center for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.; Department of Biology, Pennsylvania State University, University Park, Pennsylvania, USA.
Hudson PJ; Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, Pennsylvania, USA.; Huck Institutes of the Life Sciences and.; Department of Biology, Pennsylvania State University, University Park, Pennsylvania, USA.
Josleyn NM; US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Prugar L; US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Huie K; US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Herbert A; US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Bernard DW; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.
Dye JM; US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Kapur V; Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, Pennsylvania, USA.; Huck Institutes of the Life Sciences and.; Department of Animal Science, Pennsylvania State University, University Park, Pennsylvania, USA.
Musser JM; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.; Center for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.; Pokaż więcej
Źródło :: The Journal of clinical investigation [J Clin Invest] 2020 Dec 01; Vol. 130 (12), pp. 6728-6738.
Typ publikacji :: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Antibodies, Neutralizing*/administration & dosage
Antibodies, Neutralizing*/blood
Antibodies, Viral*/administration & dosage
Antibodies, Viral*/blood
Immunoglobulin G*/administration & dosage
Immunoglobulin G*/blood
SARS-CoV-2*
COVID-19/*therapy
Adolescent ; Adult ; Aged ; Female ; Humans ; Immunization, Passive ; Male ; Middle Aged
SCR Protocol :: COVID-19 serotherapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Preliminary validation of the use of IgG antibody response to Anopheles gSG6-p1 salivary peptide to assess human exposure to malaria vector bites in two endemic areas of Cameroon in Central Africa.
Autorzy :: Cheteug G; Malaria Research Unit, Centre Pasteur Cameroon, Yaounde, Cameroon.; Department of Microbiology and Parasitology, Faculty of Sciences, University of Buea, Buea, Cameroon.
Elanga-Ndille E; Centre for Research in Infectious Diseases, Yaounde, Cameroon.
Donkeu C; Malaria Research Unit, Centre Pasteur Cameroon, Yaounde, Cameroon.; Department of Animal Biology and Physiology, Faculty of Sciences, University of Yaounde, Yaounde, Cameroon.
Ekoko W; Parasitology and Entomology Research Unit, Department of Animal Biology and Organisms, Faculty of Sciences, University of Douala, Douala, Cameroon.
Oloume M; Department of hematology, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
Essangui E; Malaria Research Unit, Centre Pasteur Cameroon, Yaounde, Cameroon.; Parasitology and Entomology Research Unit, Department of Animal Biology and Organisms, Faculty of Sciences, University of Douala, Douala, Cameroon.
Nwane P; Biological Sciences Department, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
NSango SE; Malaria Research Unit, Centre Pasteur Cameroon, Yaounde, Cameroon.; Laboratory of Parasitology, Mycology and Virology, Postgraduate Training Unit for Health Sciences, Postgraduate School for Pure and Applied Sciences, University of Douala, Douala, Cameroon.
Etang J; Biological Sciences Department, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.; Organisation de Coordination pour la Lutte contre les Endemies en Afrique Central, Yaounde, Cameroon.
Wanji S; Department of Microbiology and Parasitology, Faculty of Sciences, University of Buea, Buea, Cameroon.
Ayong L; Malaria Research Unit, Centre Pasteur Cameroon, Yaounde, Cameroon.
Eboumbou Moukoko CE; Malaria Research Unit, Centre Pasteur Cameroon, Yaounde, Cameroon.; Biological Sciences Department, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.; Laboratory of Parasitology, Mycology and Virology, Postgraduate Training Unit for Health Sciences, Postgraduate School for Pure and Applied Sciences, University of Douala, Douala, Cameroon.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Dec 31; Vol. 15 (12), pp. e0242510. Date of Electronic Publication: 2020 Dec 31 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :: Anopheles/*parasitology
Immunoglobulin G/*blood
Insect Proteins/*immunology
Malaria, Falciparum/*epidemiology
Mosquito Vectors/*parasitology
Plasmodium falciparum/*immunology
Salivary Proteins and Peptides/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Animals ; Cameroon/epidemiology ; Child ; Child, Preschool ; Dried Blood Spot Testing ; Endemic Diseases ; Female ; Humans ; Immunoglobulin G/biosynthesis ; Infant ; Insect Proteins/blood ; Malaria, Falciparum/diagnosis ; Malaria, Falciparum/immunology ; Malaria, Falciparum/parasitology ; Male ; Middle Aged ; Prevalence ; Rural Population ; Salivary Proteins and Peptides/blood ; Urban Population
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 5 5.

Tytuł :: Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge.
Autorzy :: Maun HR; Department of Early Discovery Biochemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Vij R; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Walters BT; Department of Biochemical and Cellular Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Morando A; Department of Biochemical and Cellular Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Jackman JK; Department of Immunology Discovery, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Wu P; Department of Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Estevez A; Department of Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Chen X; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Franke Y; Department of Biomolecular Resources, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Lipari MT; Department of Early Discovery Biochemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Dennis MS; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Kirchhofer D; Department of Early Discovery Biochemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Ciferri C; Department of Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Loyet KM; Department of Biochemical and Cellular Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Yi T; Department of Immunology Discovery, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Eigenbrot C; Department of Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Lazarus RA; Department of Early Discovery Biochemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. .
Koerber JT; Department of Antibody Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. .; Pokaż więcej
Źródło :: Nature communications [Nat Commun] 2020 Dec 22; Vol. 11 (1), pp. 6435. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :: Antibodies, Monoclonal/*metabolism
Immunoglobulin G/*metabolism
Tryptases/*metabolism
Allosteric Regulation/drug effects ; Amino Acid Sequence ; Heparin/pharmacology ; Humans ; Immunoglobulin Fab Fragments/metabolism ; Immunoglobulin G/chemistry ; Models, Molecular ; Mutant Proteins/chemistry ; Protein Binding/drug effects ; Protein Multimerization ; Tryptases/chemistry
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: [Reply: considerations on the evaluation under field conditions of a rapid test for detection of IgM and IgG antibodies against SARS-CoV-2].
Autorzy :: Vidal-Anzardo M; Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú.
Solis G; Oficina General de Investigación y Transferencia Tecnológica, Instituto Nacional de Salud, Lima, Perú.
Solari L; Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú.
Minaya G; Oficina General de Investigación y Transferencia Tecnológica, Instituto Nacional de Salud, Lima, Perú.
Ayala-Quintanilla B; Oficina General de Investigación y Transferencia Tecnológica, Instituto Nacional de Salud, Lima, Perú.
Astete-Cornejo J; Centro Nacional de Salud Ocupacional y Protección del Ambiente para la Salud, Lima, Perú.
Luque-Aguilar A; Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima, Perú.
Jorge A; Laboratorio de Referencia Nacional de Bacterias de Transmisión Sexual, Instituto Nacional de Salud, Lima, Perú.
Rojas N; Laboratorio de Referencia Nacional de Virus Respiratorio, Instituto Nacional de Salud, Lima, Perú.
Cardenas F; Laboratorio de Referencia Nacional de Bacterias de Transmisión Sexual, Instituto Nacional de Salud, Lima, Perú.
Soto A; Instituto de Investigación en Ciencias Biomédicas, Facultad de Medicina Humana, Universidad Ricardo Palma, Lima, Perú.; Departamento de Medicina, Hospital Nacional Hipólito Unanue, Lima, Perú.; Pokaż więcej
Transliterated Title :: Réplica: consideraciones sobre la evaluación en condiciones de campo de una prueba serológica rápida para detección de anticuerpos IgM e IgG contra SARS-CoV-2.
Źródło :: Revista peruana de medicina experimental y salud publica [Rev Peru Med Exp Salud Publica] 2020 Dec 02; Vol. 37 (3), pp. 573-574.
Typ publikacji :: Letter; Comment
MeSH Terms :: COVID-19*
Immunoglobulin G*
Antibodies, Viral ; Humans ; Immunoglobulin M ; Pandemics ; SARS-CoV-2
: Opinia redakcyjna

Szczegóły Pełny tekst

Skocz do pozycji: 7 7.

Tytuł :: [Considerations on the evaluation under field conditions of a rapid test for detection of IgM and IgG antibodies against SARS-CoV-2].
Autorzy :: Arenas CG; Asociación Civil IMPACTA, Lima, Perú.
Montenegro-Idrogo JJ; Servicio de Medicina de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo, Lima, Perú.
Chiappe-Gonzalez AJ; Servicio de Medicina de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo, Lima, Perú.
Torre JCG; Facultad de Medicina Humana, Universidad Ricardo Palma, Lima, Perú.; Pokaż więcej
Transliterated Title :: Consideraciones sobre la evaluación en condiciones de campo de una prueba serológica rápida para detectar anticuerpos IgM e IgG contra SARS-CoV-2.
Źródło :: Revista peruana de medicina experimental y salud publica [Rev Peru Med Exp Salud Publica] 2020 Dec 02; Vol. 37 (3), pp. 571-572.
Typ publikacji :: Letter; Comment
MeSH Terms :: COVID-19*
Immunoglobulin G*
Humans ; Immunoglobulin M ; Pandemics ; SARS-CoV-2 ; Serologic Tests
: Opinia redakcyjna

Szczegóły Pełny tekst

Skocz do pozycji: 8 8.

Tytuł :: Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients.
Autorzy :: Sun B; State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Feng Y; State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Mo X; Institute of Infectious Diseases, Guangzhou Eighth people's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China.
Zheng P; State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Wang Q; Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People's Republic of China.
Li P; Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People's Republic of China.
Peng P; Institute of Infectious Diseases, Guangzhou Eighth people's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China.
Liu X; State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Chen Z; Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People's Republic of China.
Huang H; State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Zhang F; Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People's Republic of China.
Luo W; State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Niu X; State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Hu P; Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People's Republic of China.
Wang L; Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People's Republic of China.
Peng H; Institute of Infectious Diseases, Guangzhou Eighth people's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China.
Huang Z; State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Feng L; Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People's Republic of China.
Li F; Institute of Infectious Diseases, Guangzhou Eighth people's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China.
Zhang F; Institute of Infectious Diseases, Guangzhou Eighth people's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China.
Li F; Institute of Infectious Diseases, Guangzhou Eighth people's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China.
Zhong N; State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Chen L; State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.; Institute of Infectious Diseases, Guangzhou Eighth people's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China.; Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People's Republic of China.; Pokaż więcej
Źródło :: Emerging microbes & infections [Emerg Microbes Infect] 2020 Dec; Vol. 9 (1), pp. 940-948.
Typ publikacji :: Journal Article
MeSH Terms :: Antibodies, Viral/*immunology
Betacoronavirus/*immunology
Coronavirus Infections/*immunology
Immunoglobulin G/*immunology
Immunoglobulin M/*immunology
Nucleocapsid Proteins/*immunology
Pneumonia, Viral/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Aged ; Antibodies, Viral/blood ; C-Reactive Protein/analysis ; C-Reactive Protein/immunology ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques ; Coronavirus Infections/blood ; Coronavirus Infections/diagnosis ; Coronavirus Nucleocapsid Proteins ; Critical Care/statistics & numerical data ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Kinetics ; Male ; Middle Aged ; Nucleocapsid Proteins/blood ; Pandemics ; Phosphoproteins ; Pneumonia, Viral/blood ; Pneumonia, Viral/diagnosis ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/blood
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.
Autorzy :: Liu T; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Zeng G; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Leishenshan Hospital, Wuhan, Hubei, China.
Tao H; State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory for Oral Biomedicine of Ministry of Education (KLOBM), School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei, China.
Shi Y; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Wang T; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Liu T; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Guo F; Department of Obstetrics & Gynecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.; Center for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Zhou F; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Wang X; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Leishenshan Hospital, Wuhan, Hubei, China.; Pokaż więcej
Corporate Authors :: COVID-19 in Cancer Patients Research Group; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Cancer Precision Diagnosis and Treatment and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
Źródło :: International journal of cancer [Int J Cancer] 2020 Dec 01; Vol. 147 (11), pp. 3267-3269. Date of Electronic Publication: 2020 Jun 27.
Typ publikacji :: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Antibodies, Viral/*blood
Betacoronavirus/*immunology
Coronavirus Infections/*immunology
Immunoglobulin G/*blood
Neoplasms/*immunology
Neoplasms/*virology
Pneumonia, Viral/*immunology
Aged ; Antibodies, Viral/immunology ; COVID-19 ; Coronavirus Infections/blood ; Coronavirus Infections/virology ; Female ; Humans ; Immunoglobulin G/immunology ; Male ; Neoplasms/blood ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/virology ; Prevalence ; SARS-CoV-2
: Raport

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series.
Autorzy :: Sumii Y; Department of Hematology and Oncology, Okayama University Hospital, 2-5-1, Shikata-cho Kita-ku, Okayama, 700-8558, Japan.
Asada N; Department of Hematology and Oncology, Okayama University Hospital, 2-5-1, Shikata-cho Kita-ku, Okayama, 700-8558, Japan. .
Sato Y; Division of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama, Japan.; Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Ohshima KI; Department of Ophthalmology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
Makita M; Department of Hematology/Oncology, Okayama City Hospital, Okayama, Japan.
Yoshimoto Y; Department of Neurosurgery, National Hospital Organization Iwakuni Clinical Center, Iwakuni, Japan.
Sogabe Y; Department of Ophthalmology, Mitoyo General Hospital, Kagawa, Japan.
Imajo K; Department of Hematology/Oncology, Okayama City Hospital, Okayama, Japan.
Meguri Y; Department of Hematology and Oncology, Okayama University Hospital, 2-5-1, Shikata-cho Kita-ku, Okayama, 700-8558, Japan.
Ennishi D; Department of Hematology and Oncology, Okayama University Hospital, 2-5-1, Shikata-cho Kita-ku, Okayama, 700-8558, Japan.
Nishimori H; Department of Hematology and Oncology, Okayama University Hospital, 2-5-1, Shikata-cho Kita-ku, Okayama, 700-8558, Japan.
Fujii N; Department of Transfusion Medicine, Okayama University Hospital, Okayama, Japan.
Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, 2-5-1, Shikata-cho Kita-ku, Okayama, 700-8558, Japan.
Yoshino T; Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Maeda Y; Department of Hematology and Oncology, Okayama University Hospital, 2-5-1, Shikata-cho Kita-ku, Okayama, 700-8558, Japan.; Pokaż więcej
Źródło :: International journal of hematology [Int J Hematol] 2020 Dec; Vol. 112 (6), pp. 780-786. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :: Journal Article
MeSH Terms :: Immunoglobulin G*
Lymphoma, B-Cell, Marginal Zone/*drug therapy
Lymphoma, B-Cell, Marginal Zone/*radiotherapy
Lymphoma, B-Cell, Marginal Zone/*surgery
Rituximab/*therapeutic use
Aged ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Lymphoma, B-Cell, Marginal Zone/immunology ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Prognosis ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Rapid and quantitative detection of SARS-CoV-2 specific IgG for convalescent serum evaluation.
Autorzy :: Tan X; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.
Krel M; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 07110, USA.
Dolgov E; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 07110, USA.
Park S; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 07110, USA.
Li X; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.
Wu W; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.
Sun YL; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.
Zhang J; Sino Biological Inc, Beijing, 100176, China; Beijing Key Laboratory of Monoclonal Antibody Research and Development, Beijing, 100176, China.
Khaing Oo MK; Optofluidic Bioassay, LLC, Ann Arbor, MI, 48103, USA. Electronic address: .
Perlin DS; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 07110, USA. Electronic address: .
Fan X; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. Electronic address: .; Pokaż więcej
Źródło :: Biosensors & bioelectronics [Biosens Bioelectron] 2020 Dec 01; Vol. 169, pp. 112572. Date of Electronic Publication: 2020 Sep 03.
Typ publikacji :: Evaluation Study; Journal Article
MeSH Terms :: Antibodies, Viral/*blood
Betacoronavirus/*immunology
Coronavirus Infections/*virology
Enzyme-Linked Immunosorbent Assay/*instrumentation
Immunoglobulin G/*blood
Microfluidic Analytical Techniques/*instrumentation
Pneumonia, Viral/*virology
Adolescent ; Adult ; Antibodies, Viral/immunology ; Antigens, Viral/blood ; Antigens, Viral/immunology ; Biosensing Techniques/economics ; Biosensing Techniques/instrumentation ; COVID-19 ; Coronavirus Infections/therapy ; Enzyme-Linked Immunosorbent Assay/economics ; Equipment Design ; Humans ; Immunization, Passive ; Immunoglobulin G/immunology ; Limit of Detection ; Luminescent Measurements/economics ; Luminescent Measurements/instrumentation ; Microfluidic Analytical Techniques/economics ; Middle Aged ; Pandemics ; Pneumonia, Viral/therapy ; SARS-CoV-2 ; Time Factors ; Young Adult
SCR Protocol :: COVID-19 serotherapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Evaluation of plasma anti-GPL-core IgA and IgG for diagnosis of disseminated non-tuberculous mycobacteria infection.
Autorzy :: Nithichanon A; Cellular and Molecular Immunology Unit, Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.; Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Samer W; Cellular and Molecular Immunology Unit, Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
Chetchotisakd P; Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Kewcharoenwong C; Cellular and Molecular Immunology Unit, Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.; Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
Ato M; Department of Mycobacteriology, National Institute of Infectious Diseases, Tokyo, Japan.
Lertmemongkolchai G; Cellular and Molecular Immunology Unit, Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.; Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Nov 30; Vol. 15 (11), pp. e0242598. Date of Electronic Publication: 2020 Nov 30 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Antibodies, Bacterial/*immunology
Immunoglobulin A/*immunology
Immunoglobulin G/*immunology
Mycobacterium avium Complex/*immunology
Mycobacterium avium-intracellulare Infection/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Antibodies, Bacterial/blood ; Female ; Glycopeptides/immunology ; Humans ; Immunoglobulin A/blood ; Immunoglobulin G/blood ; Male ; Middle Aged ; Mycobacterium avium Complex/isolation & purification ; Mycobacterium avium-intracellulare Infection/blood ; Mycobacterium avium-intracellulare Infection/epidemiology ; Mycobacterium avium-intracellulare Infection/immunology ; Thailand/epidemiology ; Young Adult
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 13 13.

Tytuł :: Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis.
Autorzy :: Indenbaum V; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.
Koren R; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.
Katz-Likvornik S; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.
Yitzchaki M; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.
Halpern O; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.
Regev-Yochay G; School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Infection Prevention & Control Unit, Sheba Medical Center, Ramat-Gan, Israel.
Cohen C; Infection Prevention & Control Unit, Sheba Medical Center, Ramat-Gan, Israel.
Biber A; Infection Prevention & Control Unit, Sheba Medical Center, Ramat-Gan, Israel.
Feferman T; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Cohen Saban N; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Dhan R; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Levin T; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.
Gozlan Y; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.
Weil M; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.
Mor O; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Mandelboim M; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Sofer D; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.
Mendelson E; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.; School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Lustig Y; Central Virology Laboratory and Sheba Medical Center, Ministry of Health, Tel-Hashomer, Israel.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Nov 23; Vol. 15 (11), pp. e0241164. Date of Electronic Publication: 2020 Nov 23 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Pandemics*
Antibodies, Viral/*immunology
COVID-19/*diagnosis
COVID-19/*epidemiology
COVID-19 Serological Testing/*methods
Immunoglobulin G/*immunology
Protein Domains/*immunology
SARS-CoV-2/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; COVID-19/blood ; COVID-19/virology ; Cohort Studies ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Immunoglobulin A/blood ; Immunoglobulin A/immunology ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Immunoglobulin M/immunology ; Male ; Middle Aged ; Reverse Transcriptase Polymerase Chain Reaction ; SARS-CoV-2/genetics ; Sensitivity and Specificity ; Young Adult
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 14 14.

Tytuł :: SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
Autorzy :: Benner SE; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Patel EU; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Laeyendecker O; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Pekosz A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Littlefield K; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Eby Y; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Fernandez RE; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Miller J; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Kirby CS; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Keruly M; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Klock E; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Baker OR; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Schmidt HA; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Shrestha R; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Burgess I; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Bonny TS; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Clarke W; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Caturegli P; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Sullivan D; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Shoham S; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Quinn TC; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Bloch EM; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Casadevall A; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Tobian AAR; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Redd AD; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Pokaż więcej
Źródło :: The Journal of infectious diseases [J Infect Dis] 2020 Nov 13; Vol. 222 (12), pp. 1974-1984.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :: Antibody Affinity*
SARS-CoV-2*
Antibodies, Neutralizing/*administration & dosage
Antibodies, Viral/*administration & dosage
COVID-19/*therapy
Immunoglobulin G/*administration & dosage
Adolescent ; Adult ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Blood Donors ; Cohort Studies ; Cross-Sectional Studies ; Female ; Humans ; Immunization, Passive ; Immunoglobulin G/blood ; Linear Models ; Male ; Middle Aged ; Spike Glycoprotein, Coronavirus/immunology ; Young Adult
SCR Protocol :: COVID-19 serotherapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.
Autorzy :: Feng L; Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
Dong K; Department of Gastroenterology, Yantaishan Hospital, Shandong, China.
Zhang X; Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
Ma B; Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
Chen L; Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
Yang Q; Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
Chen Q; Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
Wen X; Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
Jin Q; Department of Hepatology, The First Hospital of Jilin University, Changchun, China.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Nov 12; Vol. 15 (11), pp. e0242164. Date of Electronic Publication: 2020 Nov 12 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Autoantigens/*immunology
Immunoglobulin G/*immunology
Liver Cirrhosis, Biliary/*immunology
Mitochondrial Proteins/*immunology
Aged ; Autoantigens/blood ; Biomarkers/blood ; Female ; Humans ; Immunoglobulin G/blood ; Liver Cirrhosis, Biliary/pathology ; Male ; Middle Aged
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 16 16.

Tytuł :: A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood.
Autorzy :: Wang Z; Joint National Laboratory for Antibody Drug Engineering, Key Laboratory of Cellular and Molecular Immunology of Henan Province, School of Basic Medical Sciences, Henan University, Kaifeng, 475004, China. .
Zheng Z; Joint National Laboratory for Antibody Drug Engineering, Key Laboratory of Cellular and Molecular Immunology of Henan Province, School of Basic Medical Sciences, Henan University, Kaifeng, 475004, China. .
Hu H; Joint National Laboratory for Antibody Drug Engineering, Key Laboratory of Cellular and Molecular Immunology of Henan Province, School of Basic Medical Sciences, Henan University, Kaifeng, 475004, China. .
Zhou Q; Joint National Laboratory for Antibody Drug Engineering, Key Laboratory of Cellular and Molecular Immunology of Henan Province, School of Basic Medical Sciences, Henan University, Kaifeng, 475004, China. .
Liu W; The Institute for Disease Prevention and Control of People's Liberation Army, Beijing, 100071, China.
Li X; The First Affiliated Hospital of Henan University, Kaifeng, 475004, China.
Liu Z; The First Affiliated Hospital of Henan University, Kaifeng, 475004, China.
Wang Y; Joint National Laboratory for Antibody Drug Engineering, Key Laboratory of Cellular and Molecular Immunology of Henan Province, School of Basic Medical Sciences, Henan University, Kaifeng, 475004, China. .
Ma Y; Joint National Laboratory for Antibody Drug Engineering, Key Laboratory of Cellular and Molecular Immunology of Henan Province, School of Basic Medical Sciences, Henan University, Kaifeng, 475004, China. .; Pokaż więcej
Źródło :: Lab on a chip [Lab Chip] 2020 Nov 10; Vol. 20 (22), pp. 4255-4261.
Typ publikacji :: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Clinical Laboratory Techniques*
Antibodies, Viral/*blood
Betacoronavirus/*immunology
Coronavirus Infections/*blood
Immunoglobulin G/*blood
Immunoglobulin M/*blood
Pneumonia, Viral/*blood
Antibodies, Viral/immunology ; COVID-19 ; COVID-19 Testing ; Coronavirus Infections/diagnosis ; Coronavirus Infections/immunology ; Equipment Design ; HEK293 Cells ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Lab-On-A-Chip Devices ; Limit of Detection ; Nanoparticles/chemistry ; Pandemics ; Pneumonia, Viral/immunology ; Point-of-Care Testing ; Reagent Strips/analysis ; SARS-CoV-2 ; Selenium/chemistry
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
Autorzy :: Xiang F; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang X; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
He X; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Peng Z; School of Urban Design, Wuhan University, Wuhan, China.
Yang B; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang J; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhou Q; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ye H; Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ma Y; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li H; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wei X; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cai P; Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ma WL; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Pokaż więcej
Źródło :: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Nov 05; Vol. 71 (8), pp. 1930-1934.
Typ publikacji :: Journal Article
MeSH Terms :: Clinical Laboratory Techniques/*methods
Coronavirus Infections/*diagnosis
Enzyme-Linked Immunosorbent Assay/*methods
Immunoglobulin G/*blood
Immunoglobulin M/*blood
Pneumonia, Viral/*diagnosis
Adult ; Aged ; Betacoronavirus/immunology ; COVID-19 ; COVID-19 Testing ; Case-Control Studies ; Coronavirus Infections/blood ; Female ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/blood ; Reverse Transcriptase Polymerase Chain Reaction ; SARS-CoV-2 ; Sensitivity and Specificity ; Time Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Performance of an automated chemiluminescence SARS-CoV-2 IG-G assay.
Autorzy :: Lau CS; Department of Laboratory Medicine, Changi General Hospital, Singapore.
Oh HML; Department of Infectious Diseases, Changi General Hospital, Singapore.
Hoo SP; Department of Laboratory Medicine, Changi General Hospital, Singapore.
Liang YL; Department of Laboratory Medicine, Changi General Hospital, Singapore.
Phua SK; Department of Laboratory Medicine, Changi General Hospital, Singapore.
Aw TC; Department of Laboratory Medicine, Changi General Hospital, Singapore; Department of Medicine, National University of Singapore, Singapore; Academic Pathology Program, Duke-NUS Medical School, Singapore. Electronic address: .; Pokaż więcej
Źródło :: Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2020 Nov; Vol. 510, pp. 760-766. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :: Journal Article
MeSH Terms :: Betacoronavirus/*immunology
Immunoglobulin G/*analysis
Luminescent Measurements/*methods
Adult ; Automation ; Cross Reactions ; Female ; Humans ; Immunoglobulin G/immunology ; Limit of Detection ; Male ; Middle Aged ; Predictive Value of Tests ; SARS-CoV-2
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Evaluation of Abbott anti-SARS-CoV-2 CMIA IgG and Euroimmun ELISA IgG/IgA assays in a clinical lab.
Autorzy :: Manalac J; Clinical Chemistry and Immunology Section of Clinical Laboratories, Stanford Health Care, United States.
Yee J; Clinical Chemistry and Immunology Section of Clinical Laboratories, Stanford Health Care, United States.
Calayag K; Department of Pathology, Stanford University School of Medicine, United States.
Nguyen L; Clinical Chemistry and Immunology Section of Clinical Laboratories, Stanford Health Care, United States.
Patel PM; Clinical Chemistry and Immunology Section of Clinical Laboratories, Stanford Health Care, United States.
Zhou D; Clinical Chemistry and Immunology Section of Clinical Laboratories, Stanford Health Care, United States.
Shi RZ; Clinical Chemistry and Immunology Section of Clinical Laboratories, Stanford Health Care, United States; Department of Pathology, Stanford University School of Medicine, United States. Electronic address: .; Pokaż więcej
Źródło :: Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2020 Nov; Vol. 510, pp. 687-690. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :: Evaluation Study; Journal Article
MeSH Terms :: Luminescent Measurements*
Betacoronavirus/*immunology
Enzyme-Linked Immunosorbent Assay/*methods
Immunoglobulin A/*blood
Immunoglobulin G/*blood
Humans ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Limit of Detection ; SARS-CoV-2
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: Antibody deglycosylation only eliminates IgG2b binding.
Autorzy :: Temming AR; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Bentlage AEH; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
de Taeye SW; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Bosman GP; Department of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Lissenberg-Thunnissen SN; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Derksen NIL; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Brasser G; Sanquin Reagents, Amsterdam, The Netherlands.
Mok JY; Sanquin Reagents, Amsterdam, The Netherlands.
van Esch WJE; Sanquin Reagents, Amsterdam, The Netherlands.
Howie HL; Department of Pathology, Carter Immunology Center, University of Virginia School of Medicine, Charlottesville, Virginia, United States.
Zimring JC; Department of Pathology, Carter Immunology Center, University of Virginia School of Medicine, Charlottesville, Virginia, United States.
Vidarsson G; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: G..; Pokaż więcej
Źródło :: Molecular immunology [Mol Immunol] 2020 Nov; Vol. 127, pp. 79-86. Date of Electronic Publication: 2020 Sep 15.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Antibodies/*immunology
Cross Reactions/*immunology
Immunoglobulin G/*immunology
Receptors, Fc/*immunology
Animals ; Bacterial Proteins/metabolism ; Conserved Sequence ; Glycoside Hydrolases/metabolism ; Glycosylation ; Humans ; Immunoglobulin G/chemistry ; Mice ; Polysaccharides/metabolism ; Protein Binding ; Species Specificity
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Immunoglobulin G"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język